Home > Quotes > IART
IART

Integra LifeSciences Holdings Corporation Common Stock Quote & Summary Data

$70.12
*  
0.66
0.93%
Get IART Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading IART now
Exchange: NASDAQ
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Integra LifeSciences Holdings Corporation Common Stock Intraday Chart




Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 72.05 $ 70.89
Low $ 70.02 $ 54.75

The current last sale of $70.12 is 28.07% Higher thanthe 52 week low.

P/E Ratio

ETFs with IART as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.35% PowerShares S&P SmallCap Health Care Portfolio (PSCH) -1.45 (-2.00%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

The terms "we," "our," "us," "Company" and "Integra" refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries, unless the context suggests otherwise. Integra, headquartered in Plainsboro, New Jersey, is a world leader in medical technology. The Company employs approximately 3,500 people around the world who are dedicated to limiting uncertainty for surgeons, so that they can concentrate on providing the best care for their patients. Integra offers innovative solutions, including leading regenerative technologies, specialty surgical solutions, and orthopedic solutions. Revenues grew to $882.7 million in 2015, an increase of 11% from $796.7 million in 2014. Integra was founded on an engineered collagen technology platform that can be used to repair and regenerate tissue.  ... More ...  

Risk Grade

Where does IART fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?